Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972.

NCT00915057 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis, Viral, Human

Interventions

DRUG: NRL972

Sponsor

Norgine